Grantham, Mayo, Van Otterloo & Co (GMO)’s Teradyne TER Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio TER Stock Details TER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-932	Closed	-$276K	–	719
2026 Q1	$276K	Buy	+932	New	+$260K	﹤0.01%	597
2021 Q2	–	Sell	-17,128	Closed	-$2.08M	–	841
2021 Q1	$2.08M	Sell	17,128 -600	-3%	-$75.4K	0.01%	474
2020 Q4	$2.13M	Sell	17,728 -1,500	-8%	-$153K	0.01%	433
2020 Q3	$1.53M	Sell	19,228 -69	-0.4%	-$5.85K	0.01%	453
2020 Q2	$1.63M	Sell	19,297 -6,700	-26%	-$449K	0.01%	452
2020 Q1	$1.41M	Sell	25,997 -2,792	-10%	-$177K	0.01%	453
2019 Q4	$1.96M	Sell	28,789 -5,200	-15%	-$330K	0.01%	411
2019 Q3	$1.97M	Sell	33,989 -27,400	-45%	-$1.45M	0.01%	433
2019 Q2	$2.94M	Buy	+61,389	New	+$2.79M	0.02%	387

Other funds holding TER

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s TER Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Teradyne (TER) in Q2 2026, closing a stake of 932 shares — an estimated $276K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in TER in Q2 2019 and held it in 9 quarters. The position peaked at $2.94M in Q2 2019. 1,424 funds tracked by Wall St. Rank hold TER as of Q2 2026.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Teradyne position as of Q2 2026 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 932 Teradyne shares in Q2 2026, an estimated $276K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Teradyne in Q2 2019 and held it in 9 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Teradyne position peaked at $2.94M in Q2 2019.
1,424 funds tracked by Wall St. Rank held Teradyne as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.